GigaLinx

GigaLinx is a biotechnology company specializing in a high-throughput screening platform designed for drug discovery targeting membrane proteins, such as G-protein coupled receptors (GPCRs) and ion channels. The company's proprietary technology enables the rapid and precise measurement of protein activity in a format compatible with large-scale chemical libraries. By overcoming traditional bottlenecks in membrane protein assays, GigaLinx aims to accelerate the development of novel therapeutics for a wide range of indications, including neurological and metabolic disorders. The company originated from research conducted at UT Health San Antonio and focuses on providing scalable solutions for functional drug screening.